Article

Next Generation Sequencing in Diagnosis of Multiple Myeloma

2023-07-17

Abstract excerpt

Multiple myeloma (MM) is an incurable, diverse cancer in which abnormal plasma cells produce and release monoclonal immunoglobulin (Ig), also known as monoclonal protein or M protein. MM is always preceded by monoclonal gammaglobulinemia of unknown significance (MGUS) and smoldering multiple myeloma (SMM). Diagnosis of MM is made from a bone marrow sample, which involves analysis of the appearance of plasma cells....

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: e087ffa9-d3eb-5d67-9417-f8f1f7527756
DOI: 10.20944/preprints202307.1110.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Next Generation Sequencing in Diagnosis of Multiple MyelomaDOI 10.20944/preprints202307.1110.v1Read

Utilizing next-generation sequencing in the management of multiple myeloma.Semantic proximity Read

Gene mutations in newly diagnosed multiple myeloma patients detected by next-generation sequencing technologySemantic proximity Read

A Next-Generation Sequencing Strategy for Evaluating the Most Common Genetic Abnormalities in Multiple Myeloma.Semantic proximity Read

Clinical implications of cytogenetic and molecular aberrations in multiple myelomaSemantic proximity Read

Minimal residual disease in multiple myeloma: defining the role of next generation sequencing and flow cytometry in routine diagnostic useSemantic proximity Read

A Comprehensive Review of the Genomics of Multiple Myeloma: Evolutionary Trajectories, Gene Expression Profiling, and Emerging Therapeutics.Semantic proximity Read

Deep Sequencing Reveals Myeloma Cells in Peripheral Blood in Majority of Multiple Myeloma PatientsSemantic proximity Read

Single-cell sequencing reveals the mechanisms of multiple myeloma progression: clarity or confusion?Semantic proximity Read

NGS-Based Molecular Karyotyping of Multiple Myeloma: Results from the GEM12 Clinical TrialSemantic proximity Read

Epidemiology, genetics and treatment of multiple myeloma and precursor diseases.Semantic proximity Read

High-risk genomic consensus validation for patients with newly diagnosed multiple myeloma using next-generation sequencing.Semantic proximity Read

The Evolving Role of Genomic Technologies in Multiple Myeloma: Implications for Diagnosis, Risk Stratification and Resistance.Semantic proximity Read